CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company, has been selected to exhibit SuperSaturated Oxygen (SSO 2) Therapy, which delivers high levels of dissolved oxygen directly to the ...
IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced that the first patient has been ...
CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...
Important Milestone Toward Bringing SSO 2 Therapy to the U.S. Market Simon Dixon, MBChB, chair of cardiovascular medicine at Beaumont Hospital Royal Oak and an investigator for this study, noted, “In ...
Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of "widowmaker" heart ...
American Medical Association Issues New Category III CPT Code for ZOLL Medical’s TherOx SSO2 Therapy
The Category III CPT code for SSO 2 Therapy was supported by the leadership of the Society for Cardiac Angiography and Interventions (SCAI) and the American College of Cardiology (ACC). The decision ...
ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the Centers for Medicare & Medicaid Services (CMS) ICD-10 Coordination ...
Fresh off receiving a PMA, TherOx is now in the process of being acquired by Zoll Medical, an Asahi Kasei Group Company. Additional terms of the deal were not disclosed. Irvine, CA-based TherOX is ...
SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results